1-2 of 2
Vojkan Susulic
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dasatinib Once-Daily Dose Regimen Provides Robust Anti-Leukemic Activity While Avoiding Suppression of T Cell Activation.

Gary L Schieven, Rosemary Zhang, Sidney Pitt, Kelly McGlinchey, Krista Menard, Richard Smykla, Vojkan Susulic, Mei-Li Wen, Amy Wiebesiek, Robert Townsend, Francis Y. Lee
Journal: Blood
Blood (2009) 114 (22): 2198.
https://doi.org/10.1182/blood.V114.22.2198.2198
Published: 2009
Journal Articles

Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation

Andrew E. Schade, Gary L. Schieven, Robert Townsend, Anna M. Jankowska, Vojkan Susulic, Rosemary Zhang, Hadrian Szpurka, Jaroslaw P. Maciejewski
Journal: Blood
Blood (2008) 111 (3): 1366–1377.
https://doi.org/10.1182/blood-2007-04-084814
Published: 2008